Skip to main content
. 2017 Aug 11;7(8):e016676. doi: 10.1136/bmjopen-2017-016676

Table 3.

The absolute risk reduction (ARR) of a potential complication that a patient would be willing to accept to change their route preference from oral to subcutaneous injection prophylaxis

Attribute Acceptable ARR trade-off
Bleeding complications requiring transfusion 6.98%
Wound complications requiring another surgery 4.53%
Blood clot requiring long-term medication 1.27%
Death due to PE 0.07%

ARR, absolute risk reduction; PE, pulmonary embolism.